APA (7th ed.) Citation
(2026). Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis. Rheumatology Advances in Practice.
Chicago Style (17th ed.) Citation
"Novel Use of Anifrolumab in a Young Patient with Jo-1-positive Juvenile Dermatomyositis." Rheumatology Advances in Practice 2026.
MLA (9th ed.) Citation
"Novel Use of Anifrolumab in a Young Patient with Jo-1-positive Juvenile Dermatomyositis." Rheumatology Advances in Practice, 2026.
Warning: These citations may not always be 100% accurate.